sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Oct-2014 08:43
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 451-475 out of 886.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>

Public Release: 8-Oct-2013
Pediatrics
Combination of anemia and high altitude increases poor outcomes in children with pneumonia
Pneumonia is the leading cause of death of young children around the world, and a study from an international group of researchers now finds that the risk of poor outcomes -- including persistent pneumonia, secondary infections, organ failure or death -- in children who contract pneumonia is four times higher in those who also have anemia and live at high altitudes.
World Health Organization, National Institutes of Health

Contact: Kory Dodd Zhao
kzhao2@partners.org
617-726-0274
Massachusetts General Hospital

Public Release: 8-Oct-2013
Innovation Days 2013
LSTM Professor Richard Pleass wins Prix de l'Innovation 2013
Professor Richard Pleass has won the Prix de l'Innovation 2013, also known as the Universal Biotech Innovation Prize 2013.

Contact: Clare Bebb
c.bebb@liv.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine

Public Release: 8-Oct-2013
2013 Victoria Prize rewards quest to eradicate malaria
Malaria researcher professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria.
Victorian Government

Contact: Alan Gill
gill.a@wehi.edu.au
61-419-591-102
Walter and Eliza Hall Institute

Public Release: 7-Oct-2013
AIDS
South Africa reverses mortality trend in children under 5
Over the past decade, South Africa has made a dramatic reversal in child survival -- mainly because of improvements in HIV/AIDS care, reports a study in AIDS, official journal of the International AIDS Society. AIDS is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 7-Oct-2013
6th Multilateral Initiative on Malaria Pan-African Conference
Malaria vaccine candidate reduces disease over 18 months of follow-up in phase 3 children's study
Results from a large-scale Phase 3 trial, presented today in Durban, show that the most clinically advanced malaria vaccine candidate, RTS,S, continued to protect young children and infants from clinical malaria up to 18 months after vaccination. Based on these data, GSK now intends to submit, in 2014, a regulatory application to the European Medicines Agency.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 7-Oct-2013
Proceedings of the National Academy of Sciences
Scientists find soaring variety of malaria parasites in bats
Researchers have discovered a surprising diversity of malaria parasites in West African bats as well as new evidence of evolutionary jumps to rodent hosts. Led by scientists at the American Museum of Natural History, the Max Planck Institute for Infection Biology, and the Museum für Naturkunde, Berlin, the new study reveals that two bat-infecting parasites are closely related to parasites in rodents that are commonly used to model human malaria in laboratory studies.
National Science Foundation, American Museum of Natural History, The Max Planck Society

Contact: Kendra Snyder
ksnyder@amnh.org
212-496-3419
American Museum of Natural History

Public Release: 3-Oct-2013
PLOS Neglected Tropical Diseases
Innovative approach could ultimately end deadly disease of sleeping sickness
A tag team of two bacteria, one of them genetically modified, has a good chance to reduce or even eliminate the deadly disease African trypanosomiasis, or sleeping sickness, researchers at Oregon State University conclude in a recent mathematical modeling study.
National Institutes of Health

Contact: Jan Medlock
jan.medlock@oregonstate.edu
541-737-6874
Oregon State University

Public Release: 3-Oct-2013
British Journal of Pharmacology
Component of citrus fruits found to block the formation of kidney cysts
A new study published today in British Journal of Pharmacology has identified that a component of grapefruit and other citrus fruits, naringenin, successfully blocks the formation of kidney cysts.
SouthWest London Academic Network

Contact: Tanya Gubbay
tanya.gubbay@rhul.ac.uk
01-784-443-552
Royal Holloway, University of London

Public Release: 2-Oct-2013
Nature
Scientists find insect DEET receptors, develop safe alternatives to DEET
Researchers at the University of California, Riverside have identified (1) DEET-detecting olfactory receptors in insects that cause repellency and (2) three safe compounds that mimic DEET and could one day be used to prevent the transmission of deadly vector-borne diseases. Until now, no one had a clue about which olfactory receptor insects used to avoid DEET. Without the receptors, it was impossible to apply modern technology to design new repellents to improve upon DEET.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Institute of Neurological Disorders

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 1-Oct-2013
TWAS 24th General Meeting
Bangladeshi immunologist Firdausi Qadri awarded the C.N.R. Rao Prize
Firdausi Qadri has been selected for significant contributions she gave to the field in almost 30 years of work on enteric diseases, and for her studies aimed at developing new strategies for mass immunization against some common infectious disease in developing countries, particularly in Bangladesh.

Contact: Ed Lempinen
elempinen@twas.org
39-348-920-1915
TWAS

Public Release: 1-Oct-2013
American Journal of Respiratory and Critical Care Medicine
ATS and ERS publish policy statement on disparities in respiratory health
To address the global phenomenon of disparities in respiratory health, the American Thoracic Society and the European Respiratory Society have released an official policy statement in which each pledges its commitment to reducing health disparities between the lowest and highest socioeconomic groups by continuing or initiating work with leaders from governments, academia, and other organizations to promote scientific inquiry and training, disseminate medical information and best practices, and monitor and advocate for public respiratory health.

Contact: Nathaniel Dunford
ndunford@thoracic.org
American Thoracic Society

Public Release: 30-Sep-2013
European Cancer Congress
The State of Oncology 2013
A proposal for a new financing model to tackle the major disparities that exist in the prevention, diagnosis, treatment and outcome of cancer in countries worldwide has been presented at the 2013 European Cancer Congress. While much progress has been made against cancer over the last century, a new report brings together evidence that not every patient benefits from it, nor even has the opportunity to benefit.
International Prevention Research Institute, World Prevention Alliance, and others

Contact: Mary Rice
mary.rice@riceconseil.eu
ECCO-the European CanCer Organisation

Public Release: 29-Sep-2013
Lancet Global Health
Avahan Aids initiative may have prevented 600,000 HIV infections in India over 10 years
A program funded by the Bill & Melinda Gates Foundation may have saved around 600,000 people in India from becoming infected with HIV over the course of a decade, according to a new report.
Bill & Melinda Gates Foundation

Contact: Sam Wong
sam.wong@imperial.ac.uk
44-207-594-2198
Imperial College London

Public Release: 26-Sep-2013
NIH expands Vaccine and Treatment Evaluation Units
A nationwide group of institutions that conducts clinical trials of promising candidate vaccines and therapies for infectious diseases, known as the Vaccine and Treatment Evaluation Units, has been awarded nine contracts to strengthen and broaden the scope of its research. Group Health Research Institute is one of these institutions.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute

Public Release: 26-Sep-2013
68th Brazilian Congress of Cardiology
European and Brazilian cardiology societies team up to tackle cardiovascular disease
As the European Society of Cardiology and the Brazilian Society of Cardiology team up to deliver key cardio messages at the 68th BSC Congress in Rio de Janeiro (28 September to 1 October 2013), new research underscores the essential role of cardiology specialists in Brazil.

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology

Public Release: 25-Sep-2013
Innovations save lives of mothers and children
Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015. Right now the annual global death toll of mothers and children under 5 is 6.9 million. Between 2016-2020, these innovations have the potential to save the lives of nearly 7.5 million women and children.

Contact: Marshall Hoffman
marshall@hoffmanpr.com
703-533-3535
Hoffman & Hoffman Worldwide

Public Release: 24-Sep-2013
Pfizer Pharmaceuticals supports MARC project
The Council on Health Research for Development is pleased to acknowledge the support of Pfizer Pharmaceuticals on Phase II of the Mapping African Research Ethics Review and Medicines Regulatory Capacity project.
Pfizer Pharmaceuticals

Contact: Teresa Cullen
cullen@cohred.org
41-225-918-900
COHRED

Public Release: 23-Sep-2013
Clinical Infectious Diseases
CDC, Mass. General study reveals that preventing malaria in travelers to West Africa reduces health costs
Not only do US travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves.
US Centers for Disease Control and Prevention

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Public Release: 23-Sep-2013
New investment fund will advance late-stage vaccines, other global health technologies
A new $95 million international investment fund will for the first time allow individual and institutional investors the opportunity to finance late-stage global health technologies and advance interventions to fight such challenges in low-income countries as malaria, tuberculosis, HIV/AIDS and maternal and infant mortality.

Contact: Colleen Harris
colleen@colleenharris.co.uk
44-207-223-4512
Grand Challenges Canada

Public Release: 23-Sep-2013
Proceedings of the National Academy of Sciences
Cancer-killing cells controlled by epigenetic process, new study shows
Natural killer cells are white blood cells that can kill and contain cancer and infectious diseases. USC scientists have identified a specific enzyme that controls the development of natural killer cells in the body. Understanding how that enzyme affects the natural killer cell may help focus future drug development in the fight against cancer.
National Institutes of Health, Leukemia and Lymphoma Society

Contact: Alison Trinidad
alison.trinidad@usc.edu
323-442-3941
University of Southern California - Health Sciences

Public Release: 19-Sep-2013
American Society of Clinical Pathology 2013 Annual Meeting in Chicago
New test enables early diagnosis of liver cancer
Researchers have found a way to make early liver cancer show its true colors.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 18-Sep-2013
University of Maryland researchers studying vaccine to prevent potential bird flu pandemic
Scientists at the University of Maryland School of Medicine's Center for Vaccine Development are part of nationwide vaccine research aimed at protecting adults from a new and virulent strain of avian influenza virus. The virus, called H7N9 influenza virus, emerged in China last spring. The study, sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, will help prepare for the possibility of a global pandemic.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Bill Seiler
bseiler@umm.edu
410-328-8919
University of Maryland Medical Center

Public Release: 18-Sep-2013
School of Public Health receives $390,000 grant to study alcohol use among youth acquiring HIV
Dr. Monica Swahn, professor in the School of Public Health and associate vice president for research at Georgia State University, has received a two-year, $390,000 grant from the National Institutes of Health to study the role of alcohol marketing and early alcohol use among African youth acquiring HIV.
National Institutes of Health

Contact: Frances Marine
francesmarine@gsu.edu
404-413-1504
Georgia State University

Public Release: 18-Sep-2013
Nature Communications
Scientists develop a new way to identify good fat
When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at the University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.
National Institutes of Health

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 18-Sep-2013
NIH prepares by funding new bird flu vaccine studies
Group Health Research Institute scientists are preparing for the potential pandemic spread of a new bird flu strain that caused severe disease in China earlier this year, joining seven other Vaccine and Treatment Evaluation Units funded by the National Institutes of Health to test vaccines to protect against the illness in adults. "Influenza viruses are constantly changing," said Lisa Jackson, M.D., M.P.H., a senior investigator at Group Health Research Institute.
National Institutes of Health

Contact: Rebecca Hughes
hughes.r@ghc.org
206-287-2055
Group Health Research Institute

Showing releases 451-475 out of 886.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 > >>